Sponsored by
The conclusion by the authors in the article is that this is a promising treatment, however they reported fairly average results: for recurrent glioblastoma, the median OS was 7.9 months ([95% confidence interval (CI) 6.5-9.2 months] and the median PFS was 2.6 months (95% CI 2.3-2.9 months).